更新:医务人员评估与照护疑似电子烟或雾化产品使用相关肺损伤患者的临时指南——美国,2019年10月
CDC联合FDA及州和地方卫生部门调查与使用电子烟或雾化产品相关的多州肺损伤暴发。本报告总结近期报告病例的临床特征国家监测数据,并据此为美国医务人员提供针对疑似或确诊EVALI患者的临时指南,涵盖初始临床评估、住院与治疗建议标准、患者随访、高风险人群特殊考虑及临床和公共卫生建议。
要点
- 疑似EVALI患者应进行胸部X线检查,室内空气下血氧饱和度低于95%或呼吸窘迫者建议住院。
- 根据临床情况可经验性联合使用抗生素、抗病毒药或类固醇。
- 建议采用循证烟草产品戒断策略(包括行为咨询)帮助患者停用电子烟或雾化产品。
核心结论
- CDC基于近期报告病例的国家监测数据发布了针对疑似或确诊EVALI患者的临时临床指南。
研究设计与样本
- 本报告总结国家监测数据中近期报告病例的临床特征,并据此提出临时建议。
主要发现
- 疑似EVALI患者应进行胸部X线检查,室内空气下血氧饱和度低于95%或呼吸窘迫者建议住院。
- 可根据临床情况经验性联合使用抗生素、抗病毒药或类固醇。
- 建议采用循证烟草产品戒断策略(包括行为咨询)帮助患者停用电子烟或雾化产品。
- 为减少复发风险,曾治疗EVALI的患者不应使用电子烟或雾化产品。
关键数值与推荐
- 住院建议标准:室内空气下血氧饱和度低于95%或呼吸窘迫。
- CDC建议不应使用含四氢大麻酚(THC)的电子烟或雾化产品。
- CDC建议考虑避免使用含尼古丁的电子烟或雾化产品。
- 电子烟或雾化产品绝不应由青少年、年轻成人或孕妇使用。
- 目前不使用烟草产品者不应开始使用电子烟或雾化产品。
临床怎么用
- 医务人员应以非评判性和全面方式询问患者电子烟或雾化产品使用情况。
- 对疑似EVALI患者进行胸部X线检查,并根据血氧饱和度和呼吸状态决定是否住院。
- 根据临床情况考虑经验性联合使用抗生素、抗病毒药或类固醇。
- 提供循证戒断策略(包括行为咨询)帮助患者停用电子烟或雾化产品。
- 告知曾治疗EVALI的患者不应使用电子烟或雾化产品以降低复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical partners are investigating a multistate outbreak of lung injury associated with the use of electronic cigarette (e-cigarette), or vaping, products. In late August, CDC released recommendations for health care providers regarding e-cigarette, or vaping, product use associated lung injury (EVALI) based on limited data from the first reported cases (1,2). This report summarizes national surveillance data describing clinical features of more recently reported cases and interim recommendations based on these data for U.S. health care providers caring for patients with suspected or known EVALI. It provides interim guidance for 1) initial clinical evaluation; 2) suggested criteria for hospital admission and treatment; 3) patient follow-up; 4) special considerations for groups at high risk; and 5) clinical and public health recommendations. Health care providers evaluating patients suspected to have EVALI should ask about the use of e-cigarette, or vaping, products in a nonjudgmental and thorough manner. Patients suspected to have EVALI should have a chest radiograph (CXR), and hospital admission is recommended for patients who have decreased blood oxygen (O2) saturation (<95%) on room air or who are in respiratory distress. Health care providers should consider empiric use of a combination of antibiotics, antivirals, or steroids based upon clinical context. Evidence-based tobacco product cessation strategies, including behavioral counseling, are recommended to help patients discontinue use of e-cigarette, or vaping, products. To reduce the risk of recurrence, patients who have been treated for EVALI should not use e-cigarette, or vaping, products. CDC recommends that persons should not use e-cigarette, or vaping, products that contain tetrahydrocannabinol (THC). At present, CDC recommends persons consider refraining from using e-cigarette, or vaping, products that contain nicotine. Irrespective of the ongoing investigation, e-cigarette, or vaping, products should never be used by youths, young adults, or women who are pregnant. Persons who do not currently use tobacco products should not start using e-cigarette, or vaping, products.
引用
- Siegel DA, Jatlaoui TC, Koumans EH, et al. Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31633675. doi:10.15585/mmwr.mm6841e3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。